LOXL2 and lip and oral cavity carcinoma: Immunocompromised and immunocompetent mouse models of oral cancer employed here both demonstrated significantly elevated LOXL2 levels, consistent with data in humans noted above and from Fig. 1 and the TCGA resource (Table S1).